Rational Design of Synthetic Polymers As Drug Carriers for Cancer Therapy

Liyan Qiu

DOI: https://doi.org/10.4172/2329-9053.1000e101

2013-01-01

Abstract:Copyright: © 2013 Qiu L. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited In the latest several decades, we have witnessed the striking development of synthetic polymers as drug carriers from the early issue as implant agents to update various nano-scaled drug delivery systems via transmucosal, oral or intravenous administration. Of these, polymeric nanoparticles delivering anti-cancer drugs, biomacromolecular antibody or genetic substance such as DNA or siRNA to tumor have received predominant attention. In these delivery systems, the polymers play important roles to improve the solubility, regulate the biodistribution, prolong the half-life and control the release of drug, consequently enhanced therapy efficacy and minimized side effect has been expected. By now, quite many polymers have been explored and it has been found that different pharmaceutical formulations would lead to different results. Therefore, the rational design of polymer and formulation, and then the proper combination of both of them is the prerequisite to fabricate a successful drug delivery system. The major method to design optimal polymer can be classified to top-down and bottom-up methods [1]. Bottomup design methods prepare the polymer derivations on the basis of chemical properties of polymers, while top-down design method is adopted to modify the polymer considering the requirement of cancer therapy. Using bottom-up method, it is easier for chemists to acquire a large quantity of novel polymers, but most of them finally fail to meet the demand of clinical application. On the contrary, top-down method directly aims to clinical application of polymers and the corresponding formulation. With this idea, how to synthesize objective polymer is always the difficulty for those researches working in clinic. Obviously, merging these two methods together is an ideal method to facilitate the development of functional polymers and their transfer from the lab to practical application. Herein, I focus on amphiphilic polymer design for cancer therapy.